bupivacaine liposome injectable suspension
Sponsors
Pacira Pharmaceuticals, Inc, Heron Therapeutics, Nuance Pharma (shanghai) Co., Ltd, Duke University, Rutgers, The State University of New Jersey
Conditions
AnalgesiaCesarean Section ComplicationsHealthy SubjectsHeart DiseasesKnee OsteoarthritisLiposomal BupivacaineOpioid UsePain
Phase 1
Phase 2
Phase 3
Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery
CompletedNCT02713230
Start: 2016-05-09End: 2017-07-07Updated: 2020-12-03
Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty
CompletedNCT02713178
Start: 2016-06-03End: 2017-06-30Updated: 2020-12-01
Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty
CompletedNCT05139030
Start: 2022-01-18End: 2022-07-11Updated: 2024-10-24
Phase 4
Extended Delivery of Bupivacaine Study in Herniorrhaphy
CompletedNCT04102267
Start: 2018-07-02End: 2018-10-26Updated: 2019-09-26
ESP Block for Post Cesarean Analgesia
CompletedNCT05664958
Start: 2023-04-17End: 2023-11-09Updated: 2025-02-05
Exparel Versus Bupivacaine in Post-operative Pain Control
CompletedNCT06547255
Start: 2024-08-21End: 2025-07-01Updated: 2025-08-05